Takeda Canada, Inc. is pleased to announce the approval of DEXILANT (dexlansoprazole), the first and only proton pump inhibitor (PPI) with a novel dual delayed release technology, which delivers two separate doses of medication at different times throughout the day providing improved and sustained symptom relief throughout the day and night. DEXILANT delayed release capsules 30 mg and 60 mg are indicated as a once-daily oral treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD), the healing of erosive esophagitis and the maintenance of healed erosive esophagitis. GERD, a chronic condition commonly known as acid reflux disease, affects one-third of the Canadian population and is often characterized by frequent and persistent heartburn that occurs two or more days a week.
A lump in your throat pain in your chest a chronic cough these are just some of the unexpected symptoms associated with gastro esophageal reflux disease otherwise known as gerd however it’s most often characterized by frequent and persistent heartburn that occurs two or more days a week the damage caused by gerd is not only painful but if left untreated can lead
To serious long-term complications dr. david armstrong is a gastroenterologist with mcmaster university medical center in hamilton ontario at least 60% of patients with reflux symptoms that is heartburn or regurgitation will wait at least 6 months before they consult a physician about their symptoms and i think one of the major reasons for this is that patients
Blame themselves if good is left untreated about half of the people with reflux disease will develop injuries or areas of inflammation in the esophagus at least half of the people who are taking prescription medication for their heartburn will continue to get symptoms it’s important that they understand that they don’t have to continue suffering from their heart
And symptoms there are other treatments that are available health canada has now approved excellent a novel protein pump inhibitor which is the first and only treatment with dual delayed release technology for the treatment of gerd that provides once daily treatment improving and sustained symptom relief and healing for patients for a full 24 hours excellent is
Unique because it has a new formulation what is called a dual delayed release and what is different about dex atlanta’s new ppi is that it has the early initial release like the other proton pump inhibitors so that the medication is taken up into the bloodstream but there is a second delayed release which means that more drug is then taken up later on so that it
Prolongs the effect of the drug and increases the duration of acid suppression according to a national survey of gerd patients 74% of those who had spoken to a doctor about their symptoms were given a diagnosis and of that 66% were diagnosed with either gerd or acid reflux 55% of those surveyed indicated that gerd impacts their sleep patterns and less than 20%
Of respondents 15% we’re aware that gerd could lead to serious long-term effects if left untreated we know that at least 50% of patients who are taking prescription medication for their reflux disease will continue to have symptoms because there are now new medications for gastroesophageal reflux disease it’s really important that patients who are still having
Symptoms talk to their physician because there is the option to change therapy to have additional advice about lifestyle that will improve their quality of life gayla tarah president and chief executive officer of the gastrointestinal society explains the impact gerd can have on a person’s quality of life the symptoms of gerd can include heartburn probably daily
And regurgitation of food so much so that it can interfere with the things that you do during the day and when it carries on into the evening and into the night you can’t sleep properly so the next day it interferes with your complete ability to work and play good patients react differently to different medications having a new medication on the market that delivers
That drug in a slightly different way from what’s currently going on could help some patients receive symptom relief that they don’t have now for more information about gastroesophageal reflux disease and treatment options speak with your doctor or health care provider
Transcribed from video
Patients living with GERD now have a new treatment option By Cision Canada
